Inmune Bio Inc (INMB) returns
Inmune Bio returns over 5 years
$1,000 invested in Inmune Bio five years ago was worth $78.85 at the close on October 30, 2026, with dividends reinvested: an average return of -39.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -25.6% | — | $743.59 | -0.9% |
| 3 months | -18.1% | — | $819.21 | +2.1% |
| Year to date | -7.1% | — | $929.49 | +11.7% |
| 1 year | -16.2% | — | $838.15 | +12.4% |
| 3 years | -78.6% | -40.1% | $214.50 | +88.5% |
| 5 years | -92.1% | -39.8% | $78.85 | +76.0% |
Inmune Bio return by calendar year
| Year | INMB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -7.1% | +11.7% | -18.7% |
| 2025 | -66.6% | +17.7% | -84.3% |
| 2024 | -58.5% | +24.9% | -83.4% |
| 2023 | +77.6% | +26.2% | +51.4% |
| 2022 | -37.8% | -18.2% | -19.7% |
| 2021 | -40.8% | +28.7% | -69.5% |
| 2020 | +196.9% | +18.4% | +178.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: INMB financials
No forecast, no recommendation. This page describes Inmune Bio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.